RIM
WST icon

Rampart Investment Management’s West Pharmaceutical WST Stock Holding History

Rampart Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-676
Closed -$186K – 368
2020
Q3 		$186K Sell
676
-4,695
-87% -$1.24M 0.12% 177
2020
Q2 		$1.22M Buy
+5,371
New +$1.06M 0.21% 140

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Rampart Investment Management's WST Position: Q4 2020 in Review

Rampart Investment Management sold out of West Pharmaceutical (WST) in Q4 2020, closing a stake of 676 shares — an estimated $186K sold.

Rampart Investment Management first reported a position in WST in Q2 2020 and held it in 2 quarters. The position peaked at $1.22M in Q2 2020. 593 funds tracked by Wall St. Rank hold WST as of Q4 2020.

  • Rampart Investment Management reported no remaining West Pharmaceutical position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 676 West Pharmaceutical shares in Q4 2020, an estimated $186K.
  • Rampart Investment Management first reported a position in West Pharmaceutical in Q2 2020 and held it in 2 quarters.
  • Rampart Investment Management's West Pharmaceutical position peaked at $1.22M in Q2 2020.
  • 593 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.